CDTX vs TMO · rev $1.3M vs P/E 24, rev $44.56B
Cidara Therapeutics Inc (CDTX) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported TMO revenue for 2025-12-31 was $44.56B. Net income was $6.70B. Revenue was up 3.9% from 2024-12-31 to 2025-12-31. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
CDTX currently screens at market cap $6.96B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the CDTX and TMO stock pages for the full models.
Not investment advice.